DVN
16
-5
WAT
57
2
BLK
61
-6
HBI
55
-4
FE
52
2
MPC
42
-2
HD
61
4
R
73
2
CF
50
-7
CAT
64
2
OMC
64
2
CCI
33
2
ZION
68
3
AIZ
82
2
BWA
52
4
HON
69
2
DAL
83
4
LMT
30
-4
BSX
64
-3
PEP
50
2
DVN
16
-5
WAT
57
2
BLK
61
-6
HBI
55
-4
FE
52
2
MPC
42
-2
HD
61
4
R
73
2
CF
50
-7
CAT
64
2
OMC
64
2
CCI
33
2
ZION
68
3
AIZ
82
2
BWA
52
4
HON
69
2
DAL
83
4
LMT
30
-4
BSX
64
-3
PEP
50
2
Financhill
Back

Novartis AG Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73

NVSEF
Novartis AG

Last Price:
102.43
Seasonality Move:
2.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Novartis AG Price Quote

$102.43
+2.43 (+2.43%)
(Updated: November 26, 2024 at 5:55 PM ET)

Novartis AG Key Stats

Buy
73
Novartis AG (NVSEF) is a Buy
Day range:
$100.00 - $100.00
52-week range:
$90.24 - $123.55
Dividend yield:
3.74%
P/E ratio:
14.08
P/S ratio:
4.11
P/B ratio:
4.62%
Volume:
434
Avg. volume:
44.5K
1-year change:
0.31%
Market cap:
$199.9B
Revenue:
$46.7B
EPS:
$8.53

How Much Does Novartis AG Make?

Is Novartis AG Growing As A Company?

  • What Is Novartis AG's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Novartis AG's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.85%

Novartis AG Stock Price Performance

  • Did Novartis AG Stock Go Up Last Month?
    Novartis AG share price went down by -7.56% last month
  • Did NVSEF's Share Price Rise Over The Last Year?
    NVSEF share price rose by 0.31% over the past 1 year

What Is Novartis AG 52-Week High & Low?

  • What Is Novartis AG’s 52-Week High Share Price?
    Novartis AG has traded as high as $123.55 over the past 52 weeks
  • What Is Novartis AG’s 52-Week Low Share Price?
    Novartis AG has traded as low as $90.24 over the past 52 weeks

Novartis AG Price To Free Cash Flow

Is It Risky To Buy Novartis AG?

  • How Much Debt Does Novartis AG Have?
    Total long term debt quarterly is $30.3B
  • How Much Cash Does Novartis AG Have?
    Cash and short term investments quarterly total is $14B
  • What Is Novartis AG’s Book Value Per Share?
    Book value per share is 21.67

Is Novartis AG Cash Flow Positive?

  • What Is NVSEF Cash Flow From Operations?
    Cash flow from operations (TTM) is $16B
  • What Is Novartis AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$9.4B
  • What Is Novartis AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.2B

Novartis AG Return On Invested Capital

  • Is Management Doing A Good Job?
    NVSEF return on invested capital is 25.8%
  • What Is Novartis AG Return On Assets?
    ROA measures how assets are converting to revenues and is 17.33%
  • What Is NVSEF Return On Equity?
    ROE is a measure of profitability and is 41.89%

Novartis AG Earnings Date & Stock Price

  • What Is Novartis AG's Stock Price Today?
    A single share of NVSEF can be purchased today for 100.00
  • What Is Novartis AG’s Stock Symbol?
    Novartis AG trades on the otcm under the ticker symbol: NVSEF
  • When Is Novartis AG’s Next Earnings Date?
    The next quarterly earnings date for Novartis AG is scheduled on November 27, 2024
  • When Is NVSEF's next ex-dividend date?
    Novartis AG's next ex-dividend date is March 7, 2024
  • How To Buy Novartis AG Stock?
    You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Novartis AG Competitors

  • Who Are Novartis AG's Competitors?
    Below is a list of companies who compete with Novartis AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • NLS Pharmaceutics Ltd (NLSP)

Novartis AG Dividend Yield

Novartis AG Analyst Estimates

YoY Growth Past Surprise
EPS: 84.71% 0%
Revenue: 8.93% 1.24%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 83.00
Downside from Last Price: -17%

Major Shareholders

  • How many NVSEF shares are owned by institutional investors?
    798M NVSEF shares are owned by institutional investors
  • How many NVSEF shares are owned by insiders?
    0 NVSEF shares are owned by insiders